Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study.
Minseok Albert KimSeung-Up KimDong Hyun SinnJeong Won JangYoung Suk LimSang Hoon AhnJae-Jun ShimYeon Seok SeoYang Hyun BaekSang Gyune KimYoung Seok KimJi Hoon KimWon Hyeok ChoeHyung Joon YimHyun Woong LeeJung Hyun KwonSung Won LeeJae Young JangHwi Young KimDong Hyun SinnGi Ae KimHyun YangHan Ah LeeMyeongseok KohYoung-Sun LeeMinkoo KimYoung ChangYun Joon KimJung Hwan YoonFabien ZoulimJeong-Hoon LeePublished in: Gut (2020)
The discontinuation of NA was not associated with a higher risk of either HBsAg reversion, serum HBV DNA redetection or HCC development compared with NA continuation among patients who achieved HBsAg seroclearance with NA.